Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Nightmares in midlife may point to future cognitive decline, dementia
Jul 12, 2024
The findings were seen in middle-aged and older adults from the general population who did not have Parkinson’s disease.
Models constructed to predict decline over time in MCI, mild dementia
Jul 10, 2024
For a hypothetical patient with MCI, a baseline MMSE of 28 and CSF Aβ1-42 of 925 pg/mL, an MMSE of 20 was predicted after 6.0 years and after 8.6 years with a hypothetical treatment.
Vigorous physical activity may preserve cognitive function in high-risk HTN
Jun 24, 2024
High versus low vigorous physical activity was linked to a lower risk of mild cognitive impairment, probable dementia and MCI/probable dementia in a multivariate model.
Tau PET performs well in predicting dementia in individuals with MCI
Jun 12, 2024
Tau positron emission tomography predicts all-cause dementia and Alzheimer disease dementia
Prevalence of dementia estimated at 10 percent in 2016
Oct 24, 2022
The risk for dementia reduced with each additional year of education; dementia prevalence was higher for Blacks.
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
SAGE detects conversion from mild cognitive impairment to dementia early
Dec 23, 2021
The Self-Administered Gerocognitive Examination detects the conversion from mild cognitive impairment to dementia sooner than the non-self-administered Mini-Mental State Examination.